From Cedar and Peanut allergies to Cancer Vaccines and Immunotherapeutics: This is the future of DNA vaccine technology

From Cedar and Peanut allergies to Cancer Vaccines and Immunotherapeutics: This is the future of DNA vaccine technology

One company stands on the brink of a revolution in vaccine technology that has the potential to change millions of lives with innovative DNA and RNA vaccines See the future of DNA vaccines: download the report For over 20 years the vaccines industry has pushed towards the goal of creating an effective DNA vaccine. But thus far the industry has …

If You Build It WILL They Come?

Michael H. May PhD, President & CEO, CCRM joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to present  ‘If You Build It WILL They Come?!’ Download this presentation now to find out: CCRM: Background Achievements over the past 30 Months Their Plan to Bridge the Commercialization Gap Stages of the Plan Enabling Product Development Integrating …

Been a Partner? What’s Your #PartneringPetPeeve?

In the Pharmaceutical and Biotech industries, partnering and collaborations are a frequent occurrence. Usually, a larger company will utilize a more niche company as a partner for a specific function (CROs and CMOs), or find a smaller drug discovery company that has a compound of interest. This is particularly true in the Orphan Drug industry, where small pharma companies are …

Moving Towards Personalised Medicine with Big Data Strategies

  The use of Big Data strategies is thought to have the potential to help physicians and scientists move closer to treating individuals, rather than diseases. Developing treatments that are tailored to an individual’s history and sensitivities presents many challenges, and will only be possible within a digital health care system. An article from 20 January 2011 in the U.S. News & World …

Opportunities for accelerating and up scaling commercial human cell therapy manufacturing

Kurt Gielen, Chemelot joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to present on ‘Opportunities for accelerating and up scaling commercial human cell therapy manufacturing.’ Download this presentation now to find out: What is Chemelot Campus BV? Chemelot Campus Products The reality of Regenerative Medicine Road from scientific discoveryto commercialization …and much more! Get your …

intel smartwatch parkinsons

Intel Develops Big Data Tools and Wearables to Diagnose and Study Parkinson’s

Intel has announced a partnership with the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop Big Data tools that will hopefully help diagnose this degenerative disorder earlier, and find a cure. Wearable sensors under the form of smartwatches could be the biggest progress of the last 200 years in terms of assessment tools available to diagnose and study …

Filling the Innovation Gap with Big Data

Data and information form the cornerstone of innovation, and it will take a change in mindset for the pharmaceutical industry to fill the innovation gap and change the way drug research is conducted. Drug approval has been flat for the last two decades, while the cost of drug development is constantly rising. Solid real world evidence of the drug performance …

Clinical Trials: Cooperation and Big Data Sharing is the Way Forward

Big Pharma companies are hiring Big Data analytics firms to protect privacy of shared data Important initiatives are emerging for big pharma companies to render their trials results accessible to other companies and to researchers. The spread of this tendency would make drug development more efficient and save the industry billions. Indeed, if researchers could always see which mistakes rivals …

big data big pharma

Announcing The Marriage of Big Pharma and Big Data

Novartis teams up with Google to develop “smart” lens This week a partnership between Goggle and Novartis has been announced, for the development of a “smart” contact lens to help diabetics track their blood sugar levels. This is the first big partnership made public between big pharma and big data to work together to revolutionise chronic disease monitoring and treatment. …